Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This study aims to define a safe prophylactic intravenous TXA dose with an advantage over
others in reducing total blood loss volume at secondary uncomplicated LSCS.